Experimental evidence revealed that secretion of osteoblastic CXCL12 triggers dissemination of tumor cells from the bloodstream to the target site by binding the receptor C-X-C chemokine receptor type 4 (CXCR4) located on the tumor cells (38, 39). Here, CXCL12 is linked to neoplasm.